產(chǎn)品基本信息
產(chǎn)品編號(hào)：A793925
產(chǎn)品名稱：Atrasentan
產(chǎn)品CAS：173937-91-2
規(guī)格含量：25mg
產(chǎn)品價(jià)格：面議
聯(lián)系我們:
產(chǎn)品詳細(xì)介紹
標(biāo)準(zhǔn)品編號(hào):
A793925
名稱:
Atrasentan
別名:
Altrasentan; (2R,3R,4S)-4-(1,3-Benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic Acid; (2R,3R,4S)-4-(1,3-Benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)-3-pyrrolidinecarboxylic Acid; (+)-A 127722; A 147627; ABT 627;
CAS號(hào):
173937-91-2
備用CAS:
HCl Salt: 195733-43-8
分子式:
C??H??N?O?
外觀:
白色固體
熔點(diǎn):
121-126ºC
分子量:
510.62
儲(chǔ)存:
-20°C Freezer, Under inert atmosphere
溶解度:
DMSO (Slightly), Methanol (Slightly)
類別:
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
Atrasentan is a selective antagonist of the endothelin-A (ETA) receptor and binds selectively to the ETA receptor, which may result in inhibition of endothelin-induced angiogenesis and tumor cell proliferation.
文獻(xiàn)
Bax, W., et al.: Trends Pharmacol. Sci., 15, 379 (1994); Winn, M., et al.: J. Med. Chem., 39, 1039 (1996); Wu-Wong, J., et al.: J. Pharmacol. Exp. Ther., 281, 791 (1997);
?您的位置：
